thyroid cancer

Gasless endoscopic thyroidectomy via the trans-subclavian approach versus conventional open thyroid surgery for unilateral thyroid cancer

by

Miranda-Filho, A. et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 9, 225–234 (2021). Google Scholar  Lu, Q., Zhu, X., Wang, P., Xue, S. & Chen, G. Comparisons of different approaches and incisions of thyroid surgery and selection strategy. Front. Endocrinol. (Lausanne). 14, 1166820 (2023). Google Scholar  … Read more

How GLP-1 drugs affect the body beyond weight loss and glucose control

by

Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. A recent review article published in the Journal of Clinical Investigation summarized the adverse effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dual incretin receptor agonists such as tirzepatide. Of … Read more

Thyroid Cancer Rates Remain ‘Frozen’ Amid Overdiagnosis

by

The incidence of thyroid cancer in the United States, having plateaued in 2009 after a decades-long increase, has remained stable since then, despite efforts to control an ongoing overdiagnosis of the disease, new research shows. “Although the incidence of thyroid cancer has plateaued, it remains at peak levels, suggesting that overdiagnosis remains a crucial unresolved … Read more

Thyroid Cancer Detections Due to More Screenings With GLP-1s

by

New research, with the caveat of a relatively short follow-up, adds to encouraging data showing an overall low risk of the development of thyroid cancer associated with glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment. However, a notably increased rate of thyroid cancer detections limited only to the first year after drug initiation — but … Read more

Is Radioiodine Beneficial After Thyroidectomy?

by

Patients with low-risk differentiated thyroid cancer show similar outcomes after 5 years regardless of whether they received radioactive iodine following total thyroidectomy, results from a randomized trial show, suggesting patients can be safely spared the additional radioiodine treatment, with some exceptions, including high-risk cases. “This is the first randomized, prospective trial showing that radioiodine is … Read more

GLP-1s Show No Increased Risk for Thyroid Cancer

by

In the largest study of its kind involving a diabetic population, the use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs shows no significantly increased risk for thyroid cancer, with the important caveat of the study’s relatively short follow-up period. “In this large multisite study utilizing data from 6 population-based databases, we found no … Read more